RJ is a Deloitte Consulting LLP principal and the leader of Federal Innovation and Translational Medicine in Deloitte’s Strategy Consulting practice. He specializes in top management issues critical to long-term results with a focus in the areas of enterprise strategy, customer strategy, and innovation. He serves clients in the commercial, federal, and non-profit health sectors. RJ has diverse industry knowledge and considerable experience in strategic planning, innovation planning, market entry, and competitive strategy. His recent experience includes focusing on issues related to veterans, food and drug safety, and world economic improvement.